Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. Its products include hypoglycemic drugs, anesthesia drugs, cardiovascular disease treatment drugs, and mental illness drugs. It offers fluoxetine dydrochloride dispersible tablets, isosorbide mononitrate extended-release tablets, and isosorbide mononitrate tablets. The company was founded on December 27, 2004 and is headquartered in Jinan, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company